Camber Capital Management as of March 31, 2016
Portfolio Holdings for Camber Capital Management
Camber Capital Management holds 47 positions in its portfolio as reported in the March 2016 quarterly 13F filing
Company (Ticker) |
Portfolio Weight |
Valued At |
Change in Shares |
Share Count |
Share Price |
|---|---|---|---|---|---|
| Teva Pharmaceutical Industries (TEVA) | 10.2 | $174M | 3.3M | 53.51 | |
| Mylan Nv | 5.0 | $86M | 1.9M | 46.35 | |
| Medicines Company | 4.7 | $79M | 2.5M | 31.77 | |
| Brookdale Senior Living (BKD) | 4.7 | $79M | 5.0M | 15.88 | |
| NuVasive | 4.3 | $73M | 1.5M | 48.65 | |
| St. Jude Medical | 4.0 | $69M | 1.3M | 55.00 | |
| Select Medical Holdings Corporation (SEM) | 3.9 | $66M | 5.6M | 11.81 | |
| Livanova Plc Ord (LIVN) | 3.8 | $65M | 1.2M | 53.98 | |
| Orthofix International Nv Com Stk | 3.6 | $62M | 1.5M | 41.52 | |
| Nektar Therapeutics (NKTR) | 3.6 | $62M | 4.5M | 13.75 | |
| Genomic Health | 3.6 | $61M | 2.5M | 24.77 | |
| Ldr Hldg | 3.4 | $57M | 2.3M | 25.49 | |
| Valeant Pharmaceuticals Int | 3.1 | $53M | 2.0M | 26.30 | |
| Abbvie (ABBV) | 3.0 | $51M | 900k | 57.12 | |
| Gilead Sciences (GILD) | 2.7 | $46M | 500k | 91.86 | |
| Biogen Idec (BIIB) | 2.7 | $46M | 175k | 260.32 | |
| Tenet Healthcare Corporation | 2.5 | $43M | 1.5M | 28.93 | |
| Quest Diagnostics Incorporated (DGX) | 2.5 | $43M | 600k | 71.45 | |
| Cardiovascular Systems | 2.5 | $43M | 4.1M | 10.37 | |
| Universal American | 2.5 | $42M | 5.9M | 7.14 | |
| Masimo Corporation (MASI) | 2.5 | $42M | 1.0M | 41.84 | |
| Alkermes | 2.4 | $41M | 1.2M | 34.19 | |
| Medivation | 2.2 | $38M | 825k | 45.98 | |
| Ariad Pharmaceuticals | 2.0 | $35M | 5.4M | 6.39 | |
| Endologix | 1.9 | $32M | 3.9M | 8.36 | |
| Invitae (NVTAQ) | 1.6 | $28M | 2.7M | 10.23 | |
| Sequenom | 1.4 | $24M | 17M | 1.41 | |
| Wright Medical Group Nv | 1.4 | $24M | 1.5M | 16.60 | |
| Arena Pharmaceuticals | 1.2 | $21M | 11M | 1.97 | |
| OraSure Technologies (OSUR) | 0.8 | $15M | 2.0M | 7.23 | |
| AMAG Pharmaceuticals | 0.8 | $14M | 600k | 23.40 | |
| BioScrip | 0.8 | $13M | 6.2M | 2.14 | |
| Protalix BioTherapeutics | 0.7 | $11M | 13M | 0.84 | |
| Syneron Medical Ltd ord | 0.6 | $11M | 1.5M | 7.31 | |
| Innocoll | 0.6 | $9.5M | 1.1M | 8.58 | |
| DURECT Corporation | 0.5 | $8.1M | 6.0M | 1.35 | |
| Biolase Technology | 0.4 | $7.0M | 5.3M | 1.31 | |
| Protalix Biotherapeutics Inc note 4.500% 9/1 | 0.3 | $6.0M | 9.0M | 0.67 | |
| Ptc Therapeutics I (PTCT) | 0.3 | $5.8M | 894k | 6.44 | |
| Catabasis Pharmaceuticals | 0.3 | $5.0M | 1.0M | 5.04 | |
| Epirus Biopharmaceuticals In | 0.3 | $5.0M | 1.8M | 2.69 | |
| GenMark Diagnostics | 0.2 | $3.4M | 649k | 5.27 | |
| AngioDynamics (ANGO) | 0.2 | $3.0M | 243k | 12.29 | |
| Cardica | 0.2 | $3.0M | 838k | 3.56 | |
| Unilife US | 0.1 | $1.9M | 2.8M | 0.68 | |
| Targacept Inc Conv Dtd convertible | 0.1 | $1.7M | 1.7M | 1.00 | |
| Biolase Inc warrants | 0.0 | $18k | 1.8M | 0.01 |
